Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,153 | 14,804 | 16,987 | 18,995 | 20,563 |
| TOTAL | $13,038 | $15,951 | $18,493 | $19,674 | $23,636 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $13,038 | $15,951 | $18,493 | $19,674 | $23,636 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,533 | 1,647 | 1,294 | 1,095 | 4,208 |
| Other current liabilities | 5,000 | 2,000 | 2,000 | 2,000 | N/A |
| TOTAL | $6,533 | $3,647 | $3,294 | $3,095 | $4,208 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,533 | $3,647 | $3,294 | $3,095 | $4,208 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47 | 47 | 47 | 47 | 47 |
| Retained earnings | -54,982 | -48,988 | -45,875 | -44,355 | -41,368 |
| TOTAL | $6,506 | $12,305 | $15,199 | $16,579 | $19,428 |
| Total Liabilities And Equity | $13,038 | $15,951 | $18,493 | $19,674 | $23,636 |